
|Articles|October 23, 2014
US Healthcare Reform: A Pharm Exec Digest Special
Author(s)The Pharm Exec staff
This month’s special issue of Pharm Exec Global Digest looks at..
Advertisement
This month’s special issue of Pharm Exec Global Digest looks at
- Dealing with the “side effects” of Obamacare
- The “value” of Rxs under Obamacare
- The escalating cost of US oncology care
- And more…
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
3
What's Next for Compounded Peptides: Q&A with Nate Hill
4
Pharmaceutical Executive Daily: FDA Approves Zanvastro
5




